紧急起始腹膜透析研究新进展

Recent progress in urgent-start peritoneal dialysis

终末期肾病(end-stage renal disease,ESRD)是世界范围内的重要公共卫生问题,其起病隐匿,就诊时往往需要紧急起始透析。目前,采用中心静脉置管行血液透析(hemodialysis,HD)是最常用的紧急起始透析方式,但增加导管相关感染、菌血症、血栓形成等并发症的风险,且医疗费用较高。近年来,随着自动化腹膜透析(automated peritoneal dialysis,APD)技术的不断进步,紧急起始腹膜透析(peritoneal dialysis,PD)的关注度不断上升。多数研究认为,紧急起始PD具有良好的安全性、疗效和卫生经济学效益,具有广阔的应用前景。

End stage renal disease(ESRD) has become an important public health problem worldwide.The insidious progress of ESRD often leads to the requirement of urgent-start dialysis when admitted to hospitals. Currently, hemodialysis with central vein catheterization is still the most commonly used method of urgent-start dialysis. However, this method has the risks of catheter-related infection, bacteremia, thrombosis and other complications with higher medical expenses. Due to the continuous progress of automated peritoneal dialysis technology, the interest to urgent-start peritoneal dialysis(PD) increases in recent years. Most studies show that urgent-start PD is safe, effective, favorable to health economics, and worthy of widely used.